[SCHEDULE 13G] Nasus Pharma Ltd SEC Filing

Rhea-AI Filing Summary

Nasus Pharma Ltd (NSRX): Schedule 13G filed — Dr. Ronnie Hershman reported beneficial ownership of 1,383,512 ordinary shares, representing 15.3% of the class. The filing attributes 891,187 shares to Hershman Holdings LLC (managed by Dr. Hershman) with sole voting and dispositive power; 429,307 shares are held by Phoenix Solutions Ltd., where he may be deemed to share voting and investment power; and 63,018 shares are issuable upon exercise of options exercisable within 60 days.

For Hershman Holdings LLC alone, the filing shows 891,187 shares (9.9%) with sole voting and dispositive power. The percentages are based on 9,014,105 ordinary shares outstanding as of September 30, 2025.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Nasus Pharma Ltd

(Name of Issuer)

Ordinary Shares

(Title of Class of Securities)

M7071P109

(CUSIP Number)

09/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. M7071P109

1

Names of Reporting Persons

Dr. Ronnie Hershman

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 954,205.00
6	Shared Voting Power 429,307.00
7	Sole Dispositive Power 954,205.00
8	Shared Dispositive Power 429,307.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,383,512.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

15.3 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: (1) Consists of (i) 891,187 Ordinary Shares held by Hershman Holdings LLC, over which Dr. Hershman has sole voting and investment power; (ii) 429,307 Ordinary Shares held by Phoenix Solutions Ltd., of which Dr. Hershman is the controlling shareholder and may be deemed to share voting and investment power; and (iii) 63,018 Ordinary Shares issuable to Dr. Hershman upon the exercise of share options exercisable within 60 days. (2) Based on 9,014,105 ordinary shares that the issuer has advised the Reporting Person were issued and outstanding as of September 30, 2025.

SCHEDULE 13G

CUSIP No. M7071P109

1

Names of Reporting Persons

Hershman Holdings LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 891,187.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 891,187.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

891,187.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: (1) Hershman Holdings LLC holds 891,187 ordinary shares. Dr. Ronnie Hershman, the managing member of Hershman Holdings LLC, has sole voting and dispositive power with respect to such shares. (2) Based on 9,014,105 ordinary shares that the issuer has advised the Reporting Person were issued and outstanding as of September 30, 2025.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Nasus Pharma Ltd
(b)	Address of issuer's principal executive offices: Yigal Alon 65, Tel Aviv, 6744317, Israel.
Item 2.
(a)	Name of person filing: This Statement is filed on behalf of Dr. Ronnie Hershman, and Hershman Holdings, LLC.
(b)	Address or principal business office or, if none, residence: The address of each of the Reporting Persons is: c/o Nasus Pharma Ltd. Yigal Alon 65, Tel Aviv, 6744317, Israel
(c)	Citizenship: Dr. Ronnie Hershman is a citizen of the United States. Hershman Holdings LLC is a limited liability company organized under the laws of the State of New York.
(d)	Title of class of securities: Ordinary Shares
(e)	CUSIP No.: M7071P109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: The information required by Item 4(a) is set forth in Rows 5 through 9 and 11 of the cover pages for each of the Reporting Persons and is incorporated herein by reference. The percentage set forth in this Schedule 13G is based on 9,014,105 ordinary shares that the issuer has advised the Reporting Person were issued and outstanding as of September 30, 2025. Mr. Hershman holds (i) 891,187 Ordinary Shares held by Hershman Holdings LLC, over which Dr. Hershman, the managing member of Hershman Holdings LLC, has sole voting and investment power; (ii) 429,307 Ordinary Shares held by Phoenix Solutions Ltd., of which Dr. Hershman is the controlling shareholder and may be deemed to share voting and investment power; and (iii) 63,018 Ordinary Shares issuable to Dr. Hershman upon the exercise of share options exercisable within 60 days.
(b)	Percent of class: 15.3% 9.9%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
	(ii) Shared power to vote or to direct the vote: The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
	(iii) Sole power to dispose or to direct the disposition of: The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
	(iv) Shared power to dispose or to direct the disposition of: The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dr. Ronnie Hershman

Signature:	/s/ Dr. Ronnie Hershman
Name/Title:	Dr. Ronnie Hershman
Date:	11/13/2025

Hershman Holdings LLC

Signature:	/s/ Dr. Ronnie Hershman
Name/Title:	Dr. Ronnie Hershman/Managing Member of Hershman Holdings, LLC
Date:	11/13/2025

Exhibit Information

Exhibit 1: Joint Filing Agreement

FAQ

What stake did Dr. Ronnie Hershman report in Nasus Pharma (NSRX)?

He reported beneficial ownership of 1,383,512 ordinary shares, or 15.3% of the class.

How is Dr. Hershman's ownership in NSRX structured?

It includes 891,187 shares via Hershman Holdings LLC (sole power), 429,307 shares via Phoenix Solutions Ltd. (shared power), and 63,018 option shares exercisable within 60 days.

What percentage does Hershman Holdings LLC alone own of NSRX?

Hershman Holdings LLC reported 891,187 shares, representing 9.9% of the class, with sole voting and dispositive power.

What share count was used to calculate ownership percentages for NSRX?

Percentages are based on 9,014,105 ordinary shares outstanding as of September 30, 2025.

What are Dr. Hershman's voting and dispositive powers over NSRX shares?

He reported 954,205 shares with sole voting/dispositive power and 429,307 with shared voting/dispositive power.

What form disclosed this ownership in NSRX?

A Schedule 13G reporting beneficial ownership by Dr. Ronnie Hershman and Hershman Holdings LLC.